Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
---|
05/19/1993 | EP0542554A1 Substituted N-biphenylyl lactams |
05/19/1993 | EP0542424A1 Oxytocin recepto and DNA coding for the same |
05/19/1993 | EP0541705A1 Substituted 1h-imidazol-5-yl]alkanoic acids |
05/18/1993 | US5212185 Piperidinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension |
05/18/1993 | US5212166 Antiandrogens or 5-alpha reductase inhibitors |
05/18/1993 | US5212156 Srif-related peptides and uses thereof |
05/14/1993 | CA2082787A1 Substituted n-biphenylyl lactams |
05/13/1993 | WO1993009104A1 10-acyl-dibenz(b,f) (1,4)-oxazepines and their thiazepines analo gues useful as prostaglandin antagonists |
05/13/1993 | WO1993008816A1 Pharmaceutical lysine-containing polypeptide compositions and methods of use thereof |
05/13/1993 | WO1993008815A1 Pharmaceutical dipeptide compositions and methods of use thereof |
05/13/1993 | WO1993008807A1 Phospholipid antimicrobial compositions |
05/13/1993 | WO1993008799A1 Endothelin receptor antagonists |
05/13/1993 | CA2122820A1 Endothelin receptor antagonists |
05/13/1993 | CA2122024A1 Pharmaceutical lysine-containing polypeptide compositions and methods of use thereof |
05/13/1993 | CA2118688A1 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |
05/12/1993 | EP0540969A2 Derivatives of structurally modified VIP and pharmaceutical compositions containing them |
05/12/1993 | CN1071919A Benzanilide derivatives |
05/11/1993 | US5210086 Adrenergic antagonists, urogenital disorders |
05/11/1993 | US5210081 Estrogen Replacement Therapy |
05/11/1993 | US5210017 Ligand-mediated immunofunctional hormone binding protein assay method |
05/04/1993 | US5208255 Thioester enantiomeric compounds and their therapeutic uses |
05/04/1993 | US5208246 Tetralones with pharmacological activity |
05/04/1993 | US5208243 Analgesics |
05/04/1993 | CA1317222C Increasing endogenous growth hormone |
04/30/1993 | WO1993009087A1 Ethynyl alanine amino diol compounds for treatment of hypertension |
04/30/1993 | CA2115847A1 Ethynyl alanine amino diol compounds for treatment of hypertension |
04/29/1993 | WO1993007856A1 LOW pH AQUEOUS COSMETIC GEL CONTAINING NON-IONIC POLYACRYLAMIDE DERIVATIVES |
04/29/1993 | WO1993007833A1 Biocompatible implant for the timing of ovulation in mares |
04/28/1993 | EP0539336A1 Use of L-carnitine or of acyl L-carnitine for the treatment of idiopathic oligoasthenospermias |
04/28/1993 | EP0539154A1 Acridine-1,8-dione-derivatives as therapeutic agents |
04/28/1993 | EP0539153A1 Acridine derivative as therapeutic agent |
04/28/1993 | EP0539117A1 Compounds useful as leukotriene antagonists |
04/28/1993 | EP0538367A1 Derivatives of pituitary posterior lobe hormones |
04/28/1993 | EP0538348A1 Process for producing unsaturated 17-alpha-cyanomethyl-17-beta-hydroxysteroids. |
04/28/1993 | EP0538342A1 Igf-1 and related compounds in pregnancy |
04/28/1993 | EP0403601B1 Novel somatotropins |
04/28/1993 | CN1071416A N-alkyl-3-phenyl-3-(2-alkylthiophe-noxy) propylamines |
04/27/1993 | US5206415 Modulation of gamma-aminobutyric acid receptor channel function |
04/27/1993 | CA1316928C Alpha-heterocycle substituted tolunitriles |
04/25/1993 | CA2081133A1 Pharmaceutical compounds |
04/22/1993 | CA2080950A1 Therapeutic agent |
04/22/1993 | CA2080949A1 Therapeutic agents |
04/21/1993 | EP0537915A1 N-alkyl-3-phenyl-3-(2-alkylthiophenoxy)propylamines as norepinephrine inhibitors |
04/21/1993 | EP0537437A2 Method of treating or preventing mastitis in animals with involuting mammary glands by administering recombinant cytokines |
04/21/1993 | EP0407401B1 Human relaxin formulation |
04/20/1993 | US5204364 N-imidazolyl- and n-imidazolylmethyl-derivatives of substituted bicyclic compounds |
04/20/1993 | US5204349 Treatment of preterm labor, dysmenorrhea and for stoppage of labor prior to cesarian delivery |
04/20/1993 | US5204346 Pyrazolopyridine compounds |
04/20/1993 | US5204340 Tetrahydrobenz(c,d)indole serotonin agonists |
04/15/1993 | WO1993007109A1 3,4-dihydro-4-oxo-3-(prop-2-enyl)-1-phtalazineacetic acids and derivatives, preparations thereof and drugs containing same |
04/15/1993 | CA2120606A1 3,4-dihydro-4-oxo-3-(prop-2-enyl)-1-phthalazineacetic acids and derivatives, preparations thereof and drugs containing same |
04/14/1993 | EP0536843A1 Antiandrogen-5-alpha-reductase inhibitor compositions and their preparation |
04/14/1993 | EP0536262A1 Substituted histidines |
04/13/1993 | US5202331 Therapeutic agent for dysuria comprising alpha-phenyl-alpha-pyridylalkanoic acid derivatives |
04/13/1993 | US5202321 Antihistamine, antiallergens, antiinflammatory agents |
04/13/1993 | US5202314 10-thioethyl-steroids |
04/08/1993 | CA2078723A1 Win 49596-finasteride method of use and compositions |
04/07/1993 | EP0535925A1 (Bicyclic-hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis |
04/07/1993 | EP0535924A1 (Bicyclic-azaarylmethoxy)indoles as inhibitors of leukotriene biosynthesis |
04/07/1993 | EP0535440A2 The use of L-carnitine in endangered pregnancy |
04/07/1993 | EP0535241A1 Novel leucine aminopeptidase |
04/07/1993 | CN1070645A Imidazolyl-alkenoic acids |
04/06/1993 | CA1315677C Use of epidermal growth factor |
04/01/1993 | WO1993006124A1 11β-SUBSTITUTED 14,17-ETHANOESTRATRIENES, PROCESS FOR PREPARING THESE COMPOUNDS AND THEIR USE FOR PREPARING MEDICAMENTS |
04/01/1993 | WO1993006092A1 Piperazinyl (sulfonyl)amide derivatives of camphor as oxytocin antagonists |
04/01/1993 | CA2119780A1 11.beta.-substituted 14,17-ethanoestratrienes, process for preparing these compounds and their use for preparing medicaments |
03/31/1993 | EP0534756A2 N-alkyl-3-phenyl-3-(2-halo-substituted phenoxy)propylamines as norepinephrine uptake inhibiteurs |
03/31/1993 | EP0533796A1 STEROIDAL 3-ACETIC ACID DERIVATIVES AS 5$g(a)-REDUCTASE INHIBITORS |
03/31/1993 | EP0470976B1 Processes and compositions for the isolation of human relaxin |
03/31/1993 | EP0295248B1 Liposome preparation and antibiotic |
03/31/1993 | CN1070399A Substituted amide derivatives of piperizinylcamphorsulfonyl oxytocin antagonists |
03/30/1993 | US5198533 Decapeptides |
03/30/1993 | US5198422 Complex With Aromatic Aldehyde, Sustained Release |
03/28/1993 | CA2079162A1 N-alkyl-3-phenyl-3-(2-halo-substituted phenoxy) propylamines |
03/24/1993 | EP0533268A1 Benzanilide derivatives as 5-HT1D antagonists |
03/24/1993 | EP0533244A1 Amide-substituted derivatives of spiroindanylcamphorsulfonyl oxytocin antagonists |
03/24/1993 | EP0533243A1 Hydantoin and succinimide-substituted spiroindanylcamphorsulfonyl derivatives |
03/24/1993 | EP0533242A2 Substituted derivatives of piperazinylcamphorsulfonyl oxytocin antagonists |
03/24/1993 | EP0533241A2 Substituted alkyl derivatives of piperazinylcamphorsulfonyl oxytocin antagonists |
03/24/1993 | EP0533240A2 Substituted amine derivatives of piperazinylcamphorsulfonyl oxytocin antagonists |
03/24/1993 | EP0533210A1 Protein C containing pharmaceutical preparations |
03/24/1993 | EP0533209A1 beta-sympathomimetic Protein C containing pharmaceutical preparation |
03/24/1993 | EP0211894B1 Fsh |
03/24/1993 | CA2078712A1 Composition comprising amino acids for the prevention of hypoxic damage and a process for its preparation |
03/23/1993 | US5196411 17β-acyl-3-carboxy-androsta-3,5-dienes as testosterone 5α-reductase inhibitors |
03/23/1993 | US5195700 Helicopter flight control system |
03/19/1993 | CA2078505A1 Benzanilide derivatives |
03/18/1993 | WO1993005462A1 Low speed model following velocity command system for rotary wing aircraft |
03/18/1993 | WO1993005045A1 Spirocyclic benzopyran imidazolines |
03/18/1993 | WO1993005019A1 Indole derivatives as 5-alpha-reductase inhibitor |
03/18/1993 | CA2118697A1 Indole derivatives as 5-alpha-reductase inhibitor |
03/18/1993 | CA2113818A1 Spirocyclic benzopyran imidazolines |
03/17/1993 | EP0532097A1 Piperazinyl(sulfon)amide derivatives of camphor as oxytocin antagonists |
03/17/1993 | EP0531598A1 1,4-Dihydropyridines with paf-antagonistic activity |
03/17/1993 | EP0531407A1 Analogs of glycoprotein hormones having altered immunological characteristics, efficacy and/or receptor specificity |
03/17/1993 | CN1020095C Process for dichloroaniline derivatives |
03/17/1993 | CA2078265A1 Amide-substituted derivatives of spiroindanylcamphorsulfonyl oxytocin antagonists |
03/17/1993 | CA2078264A1 Substituted derivatives of piperizinylcamphorsulfonyl oxytocin antagonists |
03/17/1993 | CA2078263A1 Substituted alkyl derivatives of piperizinylcamphorsulfonyl oxytocin antagonists |
03/17/1993 | CA2078262A1 Hydantoin and succinimide-substituted derivatives of spiroindanylcamphorsulfonyl oxytocin antagonists |